These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 27063423)
1. Butyrylcholinesterase nanocapsule as a long circulating bioscavenger with reduced immune response. Zhang P; Jain P; Tsao C; Sinclair A; Sun F; Hung HC; Bai T; Wu K; Jiang S J Control Release; 2016 May; 230():73-8. PubMed ID: 27063423 [TBL] [Abstract][Full Text] [Related]
2. Polyethylene glycosylation prolongs the circulatory stability of recombinant human butyrylcholinesterase. Chilukuri N; Parikh K; Sun W; Naik R; Tipparaju P; Doctor BP; Saxena A Chem Biol Interact; 2005 Dec; 157-158():115-21. PubMed ID: 16253215 [TBL] [Abstract][Full Text] [Related]
3. A repeated injection of polyethyleneglycol-conjugated recombinant human butyrylcholinesterase elicits immune response in mice. Chilukuri N; Sun W; Parikh K; Naik RS; Tang L; Doctor BP; Saxena A Toxicol Appl Pharmacol; 2008 Sep; 231(3):423-9. PubMed ID: 18586293 [TBL] [Abstract][Full Text] [Related]
4. Effect of polyethylene glycol conjugation on the circulatory stability of plasma-derived human butyrylcholinesterase in mice. Sun W; Luo C; Tipparaju P; Doctor BP; Saxena A Chem Biol Interact; 2013 Mar; 203(1):172-6. PubMed ID: 23220586 [TBL] [Abstract][Full Text] [Related]
5. Demonstration of in vivo stability and lack of immunogenicity of a polyethyleneglycol-conjugated recombinant CHO-derived butyrylcholinesterase bioscavenger using a homologous macaque model. Rosenberg YJ; Saxena A; Sun W; Jiang X; Chilukuri N; Luo C; Doctor BP; Lee KD Chem Biol Interact; 2010 Sep; 187(1-3):279-86. PubMed ID: 20211615 [TBL] [Abstract][Full Text] [Related]
6. Effect of polyethylene glycol modification on the circulatory stability and immunogenicity of recombinant human butyrylcholinesterase. Chilukuri N; Sun W; Naik RS; Parikh K; Tang L; Doctor BP; Saxena A Chem Biol Interact; 2008 Sep; 175(1-3):255-60. PubMed ID: 18603232 [TBL] [Abstract][Full Text] [Related]
7. Safety of administration of human butyrylcholinesterase and its conjugates with soman or VX in rats. Genovese RF; Sun W; Johnson CC; Ditargiani RC; Doctor BP; Saxena A Basic Clin Pharmacol Toxicol; 2010 May; 106(5):428-34. PubMed ID: 20050840 [TBL] [Abstract][Full Text] [Related]
8. Intrathecal delivery of fluorescent labeled butyrylcholinesterase to the brains of butyrylcholinesterase knock-out mice: visualization and quantification of enzyme distribution in the brain. Johnson ND; Duysen EG; Lockridge O Neurotoxicology; 2009 May; 30(3):386-92. PubMed ID: 19442823 [TBL] [Abstract][Full Text] [Related]
9. Safety and pharmacokinetics of human serum butyrylcholinesterase in guinea pigs. Sun W; Doctor BP; Saxena A Chem Biol Interact; 2005 Dec; 157-158():428-9. PubMed ID: 16429577 [TBL] [Abstract][Full Text] [Related]
10. Human umbilical cord perivascular cells: A novel source of the organophosphate antidote butyrylcholinesterase. Braid LR; Wood CA; Ford BN Chem Biol Interact; 2019 May; 305():66-78. PubMed ID: 30926319 [TBL] [Abstract][Full Text] [Related]
11. A novel expression cassette delivers efficient production of exclusively tetrameric human butyrylcholinesterase with improved pharmacokinetics for protection against organophosphate poisoning. Terekhov S; Smirnov I; Bobik T; Shamborant O; Zenkova M; Chernolovskaya E; Gladkikh D; Murashev A; Dyachenko I; Palikov V; Palikova Y; Knorre V; Belogurov A; Ponomarenko N; Blackburn GM; Masson P; Gabibov A Biochimie; 2015 Nov; 118():51-9. PubMed ID: 26239905 [TBL] [Abstract][Full Text] [Related]
12. Gene-delivered butyrylcholinesterase is prophylactic against the toxicity of chemical warfare nerve agents and organophosphorus compounds. Parikh K; Duysen EG; Snow B; Jensen NS; Manne V; Lockridge O; Chilukuri N J Pharmacol Exp Ther; 2011 Apr; 337(1):92-101. PubMed ID: 21205915 [TBL] [Abstract][Full Text] [Related]
13. Pseudo-catalytic scavenging: searching for a suitable reactivator of phosphorylated butyrylcholinesterase. Kovarik Z; Katalinić M; Sinko G; Binder J; Holas O; Jung YS; Musilova L; Jun D; Kuca K Chem Biol Interact; 2010 Sep; 187(1-3):167-71. PubMed ID: 20206154 [TBL] [Abstract][Full Text] [Related]
14. Pulmonary delivery of an aerosolized recombinant human butyrylcholinesterase pretreatment protects against aerosolized paraoxon in macaques. Rosenberg YJ; Laube B; Mao L; Jiang X; Hernandez-Abanto S; Lee KD; Adams R Chem Biol Interact; 2013 Mar; 203(1):167-71. PubMed ID: 23178380 [TBL] [Abstract][Full Text] [Related]
15. In vitro characterization of cationic copolymer-complexed recombinant human butyrylcholinesterase. Pope C; Uchea C; Flynn N; Poindexter K; Geng L; Brimijoin WS; Hartson S; Ranjan A; Ramsey JD; Liu J Biochem Pharmacol; 2015 Dec; 98(3):531-9. PubMed ID: 26456723 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and immunogenicity of a recombinant human butyrylcholinesterase bioscavenger in macaques following intravenous and pulmonary delivery. Rosenberg YJ; Adams RJ; Hernandez-Abanto S; Jiang X; Sun W; Mao L; Lee KD Chem Biol Interact; 2015 Dec; 242():219-26. PubMed ID: 26415620 [TBL] [Abstract][Full Text] [Related]
17. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis. Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953 [TBL] [Abstract][Full Text] [Related]
18. Butyrylcholinesterase nanodepots with enhanced prophylactic and therapeutic performance for acute organophosphorus poisoning management. Yu C; Zhao M; Pan Z; Bo Y; Zhao W; He X; Zhang J J Mater Chem B; 2021 Feb; 9(7):1877-1887. PubMed ID: 33533366 [TBL] [Abstract][Full Text] [Related]
19. Conjugates of human serum butyrylcholinesterase and nerve agents are behaviorally safe in rhesus macaques. Saxena A; Myers TM; Sipos ML Chem Biol Interact; 2021 Aug; 344():109499. PubMed ID: 33961835 [TBL] [Abstract][Full Text] [Related]
20. Prophylaxis with human serum butyrylcholinesterase protects guinea pigs exposed to multiple lethal doses of soman or VX. Saxena A; Sun W; Fedorko JM; Koplovitz I; Doctor BP Biochem Pharmacol; 2011 Jan; 81(1):164-9. PubMed ID: 20846507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]